Ischemic Stroke
A cerebrovascular event caused by obstruction of blood flow to the brain, resulting in neuronal death and neurological deficits.
TL;DR
Stroke care is defined by time — thrombolysis and thrombectomy windows are counted in minutes. Afterwards, blood pressure control and antiplatelet therapy prevent recurrence far more than any supplement.
Overview
Ischemic stroke occurs when an artery supplying the brain is occluded, most often by thromboembolism from atherosclerotic plaque, cardiac sources such as atrial fibrillation, or small vessel disease. Roughly 1.9 million neurons die per minute of untreated large vessel occlusion, which is why the entire acute care system is organised around speed. Intravenous thrombolysis is given within 4.5 hours of onset, and mechanical thrombectomy can be effective up to 24 hours in selected patients with salvageable tissue on perfusion imaging. Recognising the FAST signs and calling emergency services immediately, rather than waiting to see if symptoms settle, is the single highest-value action a member of the public can take. Secondary prevention drives long-term outcome. Blood pressure reduction is the most powerful lever, followed by high-intensity statin therapy, antiplatelet treatment or anticoagulation where atrial fibrillation is present, diabetes control and smoking cessation. Atrial fibrillation is frequently paroxysmal and missed, so prolonged cardiac monitoring after cryptogenic stroke changes management in a meaningful proportion of cases. Supplement evidence in stroke is largely cautionary. B vitamins lower homocysteine but the large trials showed limited stroke reduction and no mortality benefit. Omega-3 failed to prevent stroke in major prevention trials. Vitamin E and beta-carotene increased haemorrhagic risk signals. The honest position is that supplements have not replaced any element of proven secondary prevention.
Common Symptoms
- •Sudden one-sided facial droop
- •Arm or leg weakness on one side
- •Slurred or confused speech
- •Sudden vision loss or double vision
- •Sudden severe imbalance or vertigo
- •Sudden severe headache
Common Causes
- •Atherosclerosis of large arteries
- •Atrial fibrillation
- •Hypertension and small vessel disease
- •Diabetes
- •Smoking
- •Arterial dissection
- •Hypercoagulable states
Root Causes
Large artery atherosclerosis with plaque rupture, cardioembolism from atrial fibrillation or structural heart disease, small vessel lipohyalinosis from hypertension and diabetes, arterial dissection particularly in younger patients, hypercoagulable states, and rarely paradoxical embolism through a patent foramen ovale.
How It's Diagnosed
Diagnostic Markers
- Urgent CT or MRI brain
- CT angiography and perfusion imaging
- Carotid ultrasound
- ECG and prolonged cardiac monitoring
- Lipid panel and HbA1c
- Echocardiography
- Thrombophilia screening in younger patients
When to See a Doctor
Call emergency services immediately for sudden facial droop, arm weakness, speech difficulty, sudden vision loss, or severe unexplained dizziness with imbalance. Do not wait for symptoms to resolve — transient symptoms indicate a transient ischemic attack, which carries high early stroke risk and needs same-day assessment.
Supplements Studied For This
Folate (Vitamin B9)
Folic acid lowers homocysteine and produced a modest stroke reduction in folate-unfortified populations, with little effect where fortification exists.
Omega-3 Fatty Acids
Large randomised prevention trials found no reduction in stroke, and high doses raise atrial fibrillation risk.
Diet & Lifestyle
Suggested Pattern
The Mediterranean diet reduced stroke incidence in the PREDIMED trial, the strongest dietary evidence available. Sodium reduction supports blood pressure control, and the DASH pattern is a reasonable alternative.
Supporting Research
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III Randomized Trial (TASTE)
Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial
Citicoline for treating people with acute ischemic stroke (Cochrane Review)
Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials
Citicoline in acute ischemic stroke: A randomized controlled trial
Frequently Asked Questions
Who It Affects
Ischemic stroke accounts for around 85% of all strokes, with roughly 12 million strokes occurring worldwide each year.
Quick Facts
- •Around 1.9 million neurons die each minute during untreated large vessel occlusion
- •Thrombectomy can help up to 24 hours in selected patients with imaging-proven salvageable tissue
- •Blood pressure control is the single most effective secondary prevention measure
- •B vitamins lower homocysteine without delivering the expected stroke reduction
Lifestyle Tips
- •Treat any sudden neurological symptom as an emergency, even if it resolves
- •Get blood pressure to target — it outperforms every other prevention measure
- •Take antiplatelet or anticoagulant therapy exactly as prescribed
- •Stop smoking; risk falls substantially within a few years
- •Ask about prolonged heart rhythm monitoring if no stroke cause was found
- •Start supervised exercise rehabilitation early rather than resting
My Notes
Sign in to add personal notes
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.